Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
A method for producing a recombinant protein.
|
| gptkbp:applicationNumber |
10/780,123
|
| gptkbp:assignee |
gptkb:XYZ_Corporation
|
| gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:claims |
20
|
| gptkbp:description |
The invention relates to methods for producing proteins.
|
| gptkbp:expirationDate |
2024-02-06
|
| gptkbp:fieldOfInvention |
biotechnology
|
| gptkbp:filingDate |
2004-02-06
|
| gptkbp:firstClaim |
The method of claim 1, further comprising purification steps.
A method for producing a protein in a host cell. The method of claim 1, wherein the host cell is genetically modified. The method of claim 1, wherein the protein is produced in a fermenter. The method of claim 1, wherein the host cell is a bacterial cell. The method of claim 1, wherein the protein is secreted into the culture medium. The method of claim 1, wherein the protein is an enzyme. |
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,960 C12
|
| gptkbp:internationalClassification |
C12N_15/00
|
| gptkbp:inventor |
gptkb:John_Doe
|
| gptkbp:issueDate |
2004-09-14
|
| gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
| gptkbp:legalStatus |
active
|
| gptkbp:maintenanceFee |
paid
|
| gptkbp:ninthClaim |
The method of claim 1, wherein the protein is a therapeutic agent.
The method of claim 1, wherein the protein is an antibody. The method of claim 1, wherein the protein is a vaccine component. |
| gptkbp:patentType |
utility
|
| gptkbp:priorityDate |
2003-02-06
|
| gptkbp:relatedTo |
gptkb:US_6,123,456_C12
|
| gptkbp:technology |
recombinant DNA technology
|